| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.025 | 0.6 |